63832
Favorite this paper

Background: Malaria is concentrated in the Amazon region with the state of Rondônia accounting for 5,5% of all cases in 2016. From 2010 onwards, access to malaria diagnosis and treatment was improved by increasing the number of microscopy centers which also provide treatment. RDTs use is limited to very remote areas. Patients typically receive malaria treatment within 24 of diagnosis, though patients often delay seeking treatment on onset of symptoms. Materials and Methods: Epidemiological data from the malaria surveillance information system SIVEP was analyzed for the period 2010 to 2016. P. vivax cases who had received treated within 60 days are considered to be “probable relapses”. Results: Malaria in Rondônia is highly concentrated with 5 municipalities accounting for 81% of all P. vivax cases respectively. The state recorded an 85% reduction in “new” cases from 38,829 in 2010 to only 6,609 in 2016. When “probable relapses” are included, the total caseload dropped from 48,338 in 2010 to 8,849 in 2016. Probable relapses, in 2016, account for 22% of P. vivax cases, primarily due to poor compliance with primaquine. The largest reduction in “new” cases (-88%) was recorded in the municipality of Porto Velho, home to the state capital, where the P. vivax case load decreased from 21,311 in 2010 to 2,487 in 2016. The malaria programs in the state and municipality, with the support from the federal level, successfully negotiated significant resources for malaria control during the installation of a hydro-electrical plant in Porto Velho. This facilitated improved surveillance, increasing the network of microscopy centers, and active management informed by epidemiological trends. Conclusion: Strong political and technical support from the federal, state and municipality, with robust local management, committed and well-trained staff including microscopists, have dramatically reduced the malaria burden in the state. Compliance with radical cure remains a major challenge to eliminating P. vivax in view of the continued transmission due to the hypnozoite reservoir.